Top Markets
#1 Orochi Network Orochi Network +73.97%
#2 Bitway Bitway +26.52%
#3 Audiera Audiera +23.90%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +17.56%
#5 Pharos Pharos +16.09%
#6 SOON SOON +14.94%
#7 Taiko Taiko +14.59%
#8 Cheems Token Cheems Token +14.34%
#9 Manadia Manadia +14.25%
#10 Zilliqa Zilliqa +12.53%
Coin of the day
Orochi Network Orochi Network
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Clasificación en acciones #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Precio por acción
$50.95
Capitalización bursátil
$226.41B
Cambio (1 día)
2.58%
Cambio (1 año)
-26.16%
País
DK
Comercio Novo Nordisk A/S (NVO)

Categoría

Healthcare
Margen Operativo de Novo Nordisk A/S (NVO)
Margen Operativo al July 2026 TTM: 45.30%
Según los informes financieros más recientes y el precio de las acciones de Novo Nordisk A/S, el margen operativo actual (TTM) es 45.30%. Al final de 2024, el margen operativo era 44.19%.
Historial de Margen Operativo de Novo Nordisk A/S desde 2000 hasta 2026
Margen Operativo al final de cada año
Año Margen Operativo Cambiar
2026 (TTM) 45.30% 9.42%
2025 41.40% -6.31%
2024 44.19% 0.07%
2023 44.16% 4.45%
2022 42.28% 1.51%
2021 41.65% -2.32%
2020 42.64% -0.86%
2019 43.01% 1.80%
2018 42.25% -3.63%
2017 43.84% 1.18%
2016 43.33% -5.41%
2015 45.81% 17.95%
2014 38.84% 3.08%
2013 37.68% -0.24%
2012 37.77% 12.01%
2011 33.72% 8.49%
2010 31.08% 6.29%
2009 29.24% 7.66%
2008 27.16% 27.03%
2007 21.38% -9.14%
2006 23.53% -1.75%
2005 23.95% -0.42%
2004 24.05% -0.04%
2003 24.06% 1.31%
2002 23.75% 0.64%
2001 23.60% 15.74%
2000 20.39% 0.00%
Margen Operativo de empresas similares o competidoras
Empresa Margen Operativo Diferencia de Margen Operativo País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -99.14%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.32% -99.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -99.44%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -99.43%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
17.54% -99.61%
US
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.